0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 21-40 of 864 Articles
JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2015;313(9):886. doi:10.1001/jama.2015.0700.

JAMA Internal Medicine | 
Original Investigation | 
Wayne A. Ray, PhD; Cecilia P. Chung, MD, MPH; Katherine T. Murray, MD; et al.
JAMA Intern Med. 2015;175(3):420-427. doi:10.1001/jamainternmed.2014.6294.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Brian P. Marr, MD; David H. Abramson, MD; Gil’ad N. Cohen, MS; et al.
JAMA Ophthalmol. 2015;133(3):283-289. doi:10.1001/jamaophthalmol.2014.5079.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2015;313(8):787. doi:10.1001/jama.2015.384.

JAMA | 
Viewpoint | 
John A. Rogers, PhD, SM
JAMA. 2015;313(6):561-562. doi:10.1001/jama.2014.17915.

JAMA Dermatology | 
Notable Notes | 
Walter H. C. Burgdorf, MD; Leonard J. Hoenig, MD; R. Steven Padilla, MD, MBA
JAMA Dermatol. 2015;151(2):203. doi:10.1001/jamadermatol.2014.1769.

JAMA Dermatology | 
Original Investigation | 
Rena C. Zuo, BA; Andrea B. Apolo, MD; John J. DiGiovanna, MD; et al.
JAMA Dermatol. 2015;151(2):170-177. doi:10.1001/jamadermatol.2014.2734.
Includes: CME

JAMA | 
Viewpoint | 
Andrew A. Monte, MD; Richard D. Zane, MD; Kennon J. Heard, MD, PhD
JAMA. 2015;313(3):241-242. doi:10.1001/jama.2014.17057.

JAMA Dermatology | 
Case Report/Case Series | 
Urvi Patel, MD; Lynn Cornelius, MD; Milan J. Anadkat, MD
JAMA Dermatol. 2015;151(1):78-81. doi:10.1001/jamadermatol.2014.3207.

JAMA Ophthalmology | 
Original Investigation | 
Nicolas A. Yannuzzi, MD; Michael A. Klufas, MD; Lucy Quach, BS; et al.
JAMA Ophthalmol. 2015;133(1):32-39. doi:10.1001/jamaophthalmol.2014.3591.
Includes: CME

JAMA Ophthalmology | 
Brief Report | 
Felipe P. P. Almeida, PhD, MD; Ana Claudia De Lucca, PhD, MD; Ingrid Ursula Scott, MPH, MD; et al.
JAMA Ophthalmol. 2015;133(1):85-88. doi:10.1001/jamaophthalmol.2014.3869.

JAMA | 
Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(24):2608. doi:10.1001/jama.2014.17033.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(23):2482. doi:10.1001/jama.2014.16135.

JAMA Internal Medicine | 
Research Letter | 
Michael A. Yokell, ScB; M. Kit Delgado, MD, MS; Nickolas D. Zaller, PhD; et al.
JAMA Intern Med. 2014;174(12):2034-2037. doi:10.1001/jamainternmed.2014.5413.

JAMA Ophthalmology | 
Invited Commentary | 
Hendrik P. N. Scholl, MD, MA; Syed Mahmood Ali Shah, MBBS
JAMA Ophthalmol. 2014;132(12):1460-1461. doi:10.1001/jamaophthalmol.2014.4090.

JAMA Ophthalmology | 
Original Investigation | 
Ronald B. Melles, MD; Michael F. Marmor, MD
JAMA Ophthalmol. 2014;132(12):1453-1460. doi:10.1001/jamaophthalmol.2014.3459.
Includes: Supplemental Content

JAMA Neurology | 
Editorial | 
Fan Liao, PhD; David M. Holtzman, MD
JAMA Neurol. 2014;71(12):1475-1476. doi:10.1001/jamaneurol.2014.2802.

JAMA Dermatology | 
Notable Notes | 
Walter H. C. Burgdorf, MD; Leonard J. Hoenig, MD
JAMA Dermatol. 2014;150(11):1151. doi:10.1001/jamadermatol.2014.81.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(15):1504. doi:10.1001/jama.2014.12463.

JAMA | 
The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(13):1280-1281. doi:10.1001/jama.2013.279755.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncology
Invited Commentary  | 
JAK/STAT Pathway Inhibitors and Neurologic Toxicity:  Above All Else Do No Harm?
Bart L. Scott, MD; Pamela S. Becker, MD, PhD
JAMA Oncology
Original Investigation  | 
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis:  A Randomized Clinical Trial
Animesh Pardanani, MD; Claire Harrison, MD; Jorge E. Cortes, MD; et al.
JAMA
Medical News & Perspectives  | 
Margaret A. Hamburg, MD, Reflects on 6 Years at FDA
Rita Rubin, MA